BBIO FY 2019 Earnings — BridgeBio Pharma, Inc. Revenue & Financial Results | Market Cap Arena

BBIOBridgeBio Pharma, Inc.

$14B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M

Gross Profit

$38M93.8% margin

Operating Income

-$266M-656.4% margin

Net Income

-$260M-642.1% margin

EPS (Diluted)

$-2.48

Cash Flow

Operating Cash Flow

-$254M

Free Cash Flow

-$259M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$632M

Total Liabilities

$156M

Stockholders' Equity

$408M

Cash & Equivalents

$364M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$0	—
Gross Profit	$38M	$0	—
Operating Income	-$266M	-$184M	-45.0%
Net Income	-$260M	-$131M	-99.2%